Published in Cell Mol Life Sci on October 15, 2009
Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci (2012) 3.11
Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology (2011) 1.31
Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders. J Neural Transm (Vienna) (2010) 1.25
Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull (2010) 1.19
A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet (2013) 1.12
Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain. J Pharmacol Exp Ther (2011) 1.00
Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology (2011) 0.98
Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochem Pharmacol (2012) 0.94
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia. ACS Med Chem Lett (2012) 0.94
Lysine metabolism in mammalian brain: an update on the importance of recent discoveries. Amino Acids (2013) 0.90
Branched-chain amino acids alter neurobehavioral function in rats. Am J Physiol Endocrinol Metab (2012) 0.88
Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor. Schizophr Bull (2014) 0.88
Kynurenines, neurodegeneration and Alzheimer's disease. J Cell Mol Med (2010) 0.87
Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations. Protein Cell (2010) 0.86
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. J Neural Transm (Vienna) (2011) 0.85
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines. J Cell Mol Med (2011) 0.83
Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. BMC Biochem (2010) 0.82
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions. ACS Med Chem Lett (2012) 0.82
Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster. Biochem J (2012) 0.82
Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV. Biosci Rep (2011) 0.81
Kynurenines in Parkinson's disease: therapeutic perspectives. J Neural Transm (Vienna) (2011) 0.80
Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain. J Neurochem (2012) 0.80
Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats. J Neural Transm (Vienna) (2011) 0.79
Molecular function prediction for a family exhibiting evolutionary tendencies toward substrate specificity swapping: recurrence of tyrosine aminotransferase activity in the Iα subfamily. Proteins (2013) 0.78
Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid. Int J Tryptophan Res (2010) 0.78
Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution. Int J Mol Sci (2016) 0.78
Characteristic features of kynurenine aminotransferase allosterically regulated by (alpha)-ketoglutarate in cooperation with kynurenine. PLoS One (2012) 0.77
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J Neuroinflammation (2015) 0.76
Alternative kynurenic acid synthesis routes studied in the rat cerebellum. Front Cell Neurosci (2015) 0.76
Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice. Brain Res (2012) 0.76
The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications. J Neural Transm (Vienna) (2012) 0.76
Kynurenines and other novel therapeutic strategies in the treatment of dementia. Ther Adv Neurol Disord (2013) 0.75
Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci (2017) 0.75
Kynurenine Aminotransferase Isozyme Inhibitors: A Review. Int J Mol Sci (2016) 0.75
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System. Int J Mol Sci (2015) 0.75
The presence of kynurenine aminotransferases in the human cornea: Evidence from bioinformatics analysis of gene expression and immunohistochemical staining. Mol Vis (2017) 0.75
Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney. Biochem Biophys Rep (2016) 0.75
Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan degradation by producing kynurenic acid in Saccharomyces cerevisiae. Sci Rep (2017) 0.75
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
Learning induces long-term potentiation in the hippocampus. Science (2006) 7.46
Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev (2009) 5.64
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J (1991) 5.30
Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations. Annu Rev Biochem (2004) 3.93
Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol (2004) 3.17
Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov (2002) 2.61
The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci (2001) 2.61
Aminotransferases: demonstration of homology and division into evolutionary subgroups. Eur J Biochem (1993) 2.59
Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther (2002) 2.37
The manifold of vitamin B6 dependent enzymes. Structure (2000) 2.27
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem (2006) 2.16
Long-term plasticity of intrinsic excitability: learning rules and mechanisms. Learn Mem (2003) 2.15
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain (1992) 2.09
Structure, evolution and action of vitamin B6-dependent enzymes. Curr Opin Struct Biol (1998) 2.03
Modeling of the spatial structure of eukaryotic ornithine decarboxylases. Protein Sci (1995) 2.02
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem (1991) 2.01
Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol (2003) 1.99
The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol (2004) 1.92
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett (2001) 1.89
A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem (1989) 1.82
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci (1992) 1.79
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease. Exp Neurol (2005) 1.79
Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J (2007) 1.68
The alpha-aminoadipate pathway for lysine biosynthesis in fungi. Cell Biochem Biophys (2006) 1.59
Evolutionary recruitment of biochemically specialized subdivisions of Family I within the protein superfamily of aminotransferases. J Bacteriol (1996) 1.59
Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem Pharmacol (2005) 1.57
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand (2003) 1.51
X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. J Mol Biol (1992) 1.49
Lysine biosynthesis and metabolism in fungi. Nat Prod Rep (2000) 1.45
Unconventional ligands and modulators of nicotinic receptors. J Neurobiol (2002) 1.43
Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. J Mol Biol (1994) 1.32
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res (2005) 1.32
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. J Neurochem (2005) 1.31
Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs (2009) 1.30
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Role of the medulla oblongata in hypertension. Hypertension (2001) 1.24
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci (2004) 1.23
The kynurenic acid hypothesis of schizophrenia. Physiol Behav (2007) 1.22
Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol (1992) 1.22
The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem Int (2004) 1.21
X-ray crystallographic study of pyridoxal 5'-phosphate-type aspartate aminotransferases from Escherichia coli in open and closed form. J Biochem (1994) 1.21
Refinement and comparisons of the crystal structures of pig cytosolic aspartate aminotransferase and its complex with 2-methylaspartate. J Biol Chem (1997) 1.20
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur J Neurosci (2009) 1.20
Kynurenine aminotransferase and glutamine transaminase K of Escherichia coli: identity with aspartate aminotransferase. Biochem J (2001) 1.19
Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Hypertension (2000) 1.19
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol (2009) 1.18
Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol (2001) 1.18
X-ray crystallographic study of pyridoxamine 5'-phosphate-type aspartate aminotransferases from Escherichia coli in three forms. J Biochem (1994) 1.17
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem (2007) 1.15
Kynurenine pathway abnormalities in Parkinson's disease. Neurology (1992) 1.14
Crystal structure of diaminopelargonic acid synthase: evolutionary relationships between pyridoxal-5'-phosphate-dependent enzymes. J Mol Biol (1999) 1.14
Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm (Vienna) (2006) 1.12
Glutamate transport and metabolism in astrocytes. Glia (1997) 1.11
Kynurenine metabolism in Alzheimer's disease. J Neural Transm (Vienna) (1999) 1.11
Dual substrate recognition of aminotransferases. Chem Rec (2005) 1.10
Early kynurenergic impairment in Huntington's disease and in a transgenic animal model. Neurosci Lett (2000) 1.09
Response of brain amino acid metabolism to ketosis. Neurochem Int (2005) 1.08
Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res (1997) 1.08
Crystal structure of human kynurenine aminotransferase I. J Biol Chem (2004) 1.08
Differential distribution of the enzymes glutamate dehydrogenase and aspartate aminotransferase in cortical synaptic mitochondria contributes to metabolic compartmentation in cortical synaptic terminals. Neurochem Int (2000) 1.07
Two kynurenine aminotransferases in human brain. Brain Res (1991) 1.07
Tryptophan metabolites and brain disorders. Clin Chem Lab Med (2003) 1.05
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem (2004) 1.04
Crystal structures of Paracoccus denitrificans aromatic amino acid aminotransferase: a substrate recognition site constructed by rearrangement of hydrogen bond network. J Mol Biol (1998) 1.04
Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures. Neurochem Res (1988) 1.03
Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. Adv Pharmacol (1994) 1.02
The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci (2009) 1.02
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Mol Cell Biol (2004) 1.01
Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis (2003) 1.01
Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney. J Biol Chem (1995) 1.01
Crystal structure of human kynurenine aminotransferase II. J Biol Chem (2007) 1.00
Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch Biochem Biophys (2008) 1.00
Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev Neurosci (1993) 1.00
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem (2002) 0.99
Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: differences revealed using aminooxyacetate. Dev Neurosci (1993) 0.99
Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep (2008) 0.99
Alpha-Aminoadipate aminotransferase and kynurenine aminotransferase. Purification, characterization, and further evidence for identity. J Biol Chem (1977) 0.99
Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. J Biol Chem (2007) 0.98
New promises for manipulation of kynurenine pathway in cancer and neurological diseases. Expert Opin Ther Targets (2009) 0.98
Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol (2008) 0.98
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur J Neurosci (2007) 0.96
Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res (2005) 0.96
Crystal structures of Aedes aegypti alanine glyoxylate aminotransferase. J Biol Chem (2006) 0.96
Identification of formyl kynurenine formamidase and kynurenine aminotransferase from Saccharomyces cerevisiae using crystallographic, bioinformatic and biochemical evidence. Biochemistry (2008) 0.96
Crystal structure of the closed form of chicken cytosolic aspartate aminotransferase at 1.9 A resolution. J Mol Biol (1995) 0.95
Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene (2006) 0.95
alpha-Aminoadipate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus. Microbiology (2004) 0.95
Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate. Glia (1996) 0.93
Evidence that aspartate aminotransferase activity and ketodicarboxylate carrier function are essential for biosynthesis of transmitter glutamate. J Neurochem (1988) 0.93
A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats. J Biol Chem (2002) 0.93
Kynurenine pathway and disease: an overview. CNS Neurol Disord Drug Targets (2007) 0.93
Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells. Arch Toxicol (2003) 0.93
Evidence of phenylalanine transaminase activity in the isoenzymes of aspartate transaminase. J Biol Chem (1972) 0.93
Use of beta-methylene-D,L-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J Neurochem (1983) 0.92
Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions. Biochem J (2002) 0.91
Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies. J Neural Transm Suppl (2006) 0.91
New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes. Dev Neurosci (1996) 0.91
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br J Pharmacol (2006) 0.90
Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5' terminal nucleotide. Cell (2008) 9.02
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med (2015) 5.69
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics (2005) 4.60
Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science (2007) 4.03
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol (2009) 3.28
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell (2012) 2.87
KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res (2006) 2.59
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet (2011) 2.34
Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell (2013) 2.17
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease. Exp Neurol (2005) 1.79
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol (2005) 1.76
Melanization immune responses in mosquito vectors. Trends Parasitol (2005) 1.71
The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma (2007) 1.65
Drosophila tan encodes a novel hydrolase required in pigmentation and vision. PLoS Genet (2005) 1.59
The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation. Gene (2006) 1.56
Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk (2010) 1.49
Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations. Leuk Lymphoma (2014) 1.45
Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis (2011) 1.40
Novel microRNAs uncovered by deep sequencing of small RNA transcriptomes in bread wheat (Triticum aestivum L.) and Brachypodium distachyon (L.) Beauv. Funct Integr Genomics (2009) 1.39
Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol (2011) 1.38
Identification of Drosophila melanogaster yellow-f and yellow-f2 proteins as dopachrome-conversion enzymes. Biochem J (2002) 1.37
Addition of amines to nitriles catalyzed by ytterbium amides: an efficient one-step synthesis of monosubstituted N-arylamidines. Org Lett (2008) 1.35
Regulatory targets of quorum sensing in Vibrio cholerae: evidence for two distinct HapR-binding motifs. Nucleic Acids Res (2009) 1.28
DTF1 is a core component of RNA-directed DNA methylation and may assist in the recruitment of Pol IV. Proc Natl Acad Sci U S A (2013) 1.27
Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol (2004) 1.23
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci (2004) 1.23
Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem (2006) 1.22
miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Lett (2011) 1.21
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum Mol Genet (2002) 1.20
Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J Biochem (2007) 1.18
The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein. Genomics (2002) 1.09
H3.3-H4 tetramer splitting events feature cell-type specific enhancers. PLoS Genet (2013) 1.09
BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett (2008) 1.08
Crystal structure of human kynurenine aminotransferase I. J Biol Chem (2004) 1.08
PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain. Genomics (2002) 1.05
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem (2004) 1.04
Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat (2012) 1.04
The splicing machinery promotes RNA-directed DNA methylation and transcriptional silencing in Arabidopsis. EMBO J (2013) 1.04
Major chorion proteins and their crosslinking during chorion hardening in Aedes aegypti mosquitoes. Insect Biochem Mol Biol (2006) 1.03
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Mol Cell Biol (2004) 1.01
Crystal structure of human kynurenine aminotransferase II. J Biol Chem (2007) 1.00
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Bioorg Med Chem Lett (2012) 1.00
Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch Biochem Biophys (2008) 1.00
Disruption of an N-acetyltransferase gene in the silkworm reveals a novel role in pigmentation. Development (2010) 1.00
A gain-of-function mutation in the Arabidopsis disease resistance gene RPP4 confers sensitivity to low temperature. Plant Physiol (2010) 1.00
SET-domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. EMBO Rep (2013) 0.99
Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep (2008) 0.99
Select small core structure carbamates exhibit high contact toxicity to "carbamate-resistant" strain malaria mosquitoes, Anopheles gambiae (Akron). PLoS One (2012) 0.98
Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol (2008) 0.98
Conditional production of acyl-homoserine lactone-type quorum-sensing signals in clinical isolates of enterobacteria. J Med Microbiol (2006) 0.98
Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res (2005) 0.97
Melanization in living organisms: a perspective of species evolution. Protein Cell (2010) 0.96
Striatal neurochemical changes in transgenic models of Huntington's disease. J Neurosci Res (2002) 0.96
Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. PLoS One (2011) 0.96
Crystal structures of Aedes aegypti alanine glyoxylate aminotransferase. J Biol Chem (2006) 0.96
Deletion of the secretory vesicle proteins IA-2 and IA-2beta disrupts circadian rhythms of cardiovascular and physical activity. FASEB J (2009) 0.96
Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology (2014) 0.95
Serine proteinase over-expression in relation to deltamethrin resistance in Culex pipiens pallens. Arch Biochem Biophys (2005) 0.95
Purification and primary structural characterization of prophenoloxidases from Aedes aegypti larvae. Insect Biochem Mol Biol (2005) 0.95
Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene (2006) 0.95
Proteomics reveals novel components of the Anopheles gambiae eggshell. J Insect Physiol (2010) 0.95
The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline. Stem Cell Res Ther (2013) 0.94
Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res (2008) 0.94
From L-dopa to dihydroxyphenylacetaldehyde: a toxic biochemical pathway plays a vital physiological function in insects. PLoS One (2011) 0.92
3-Hydroxykynurenine transaminase identity with alanine glyoxylate transaminase. A probable detoxification protein in Aedes aegypti. J Biol Chem (2002) 0.92
The LuxR family quorum-sensing activator MrtR requires its cognate autoinducer for dimerization and activation but not for protein folding. J Bacteriol (2008) 0.92
Crystal structure and substrate specificity of Drosophila 3,4-dihydroxyphenylalanine decarboxylase. PLoS One (2010) 0.92
The VarS/VarA two-component system modulates the activity of the Vibrio cholerae quorum-sensing transcriptional regulator HapR. Microbiology (2011) 0.92
Molecular characterization of a novel peroxidase involved in Aedes aegypti chorion protein crosslinking. Insect Biochem Mol Biol (2004) 0.92
Increased Notch pathway activation in Behçet's disease. Rheumatology (Oxford) (2014) 0.91
Purification and N-glycosylation analysis of melanoma antigen dopachrome tautomerase. Protein J (2010) 0.91
Mitochondrial location of severe acute respiratory syndrome coronavirus 3b protein. Mol Cells (2006) 0.90
Properties of Drosophila melanogaster prophenoloxidases expressed in Escherichia coli. Dev Comp Immunol (2011) 0.90
Determination of the Plasmodium vivax schizont stage proteome. J Proteomics (2011) 0.90
Puf mediates translation repression of transmission-blocking vaccine candidates in malaria parasites. PLoS Pathog (2013) 0.90
Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminase. Proc Natl Acad Sci U S A (2006) 0.90
Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K. J Med Chem (2009) 0.89
Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells. Virol J (2007) 0.89
Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia. Leuk Lymphoma (2013) 0.89
RESP18, a homolog of the luminal domain IA-2, is found in dense core vesicles in pancreatic islet cells and is induced by high glucose. J Endocrinol (2007) 0.89
BAG3: a new therapeutic target of human cancers? Histol Histopathol (2012) 0.88
The tryptophan oxidation pathway in mosquitoes with emphasis on xanthurenic acid biosynthesis. J Insect Physiol (2006) 0.88
Enzymatic transformation of nonfood biomass to starch. Proc Natl Acad Sci U S A (2013) 0.88
Aryl methylcarbamates: potency and selectivity towards wild-type and carbamate-insensitive (G119S) Anopheles gambiae acetylcholinesterase, and toxicity to G3 strain An. gambiae. Chem Biol Interact (2012) 0.87
Diagnosis of schistosomiasis japonica with interfacial co-assembly-based multi-channel electrochemical immunosensor arrays. Sci Rep (2013) 0.87
The structure of receptor-associated protein (RAP). Protein Sci (2007) 0.87
Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations. Protein Cell (2010) 0.86
Identification of a novel Cys146X mutation of SOD1 in familial amyotrophic lateral sclerosis by whole-exome sequencing. Genet Med (2012) 0.86